Abstract:Abstract BackgroundNon-steroidal anti-inflammatory drugs (NSAIDs) are the world's most used drugs with anti-inflammatory, analgesic and antipyretic effects. 2-arylpropionate drugs are a very important class of chiral drugs in NSAIDs. In the pharmaceutical industry, there is an increasing demand for esterase-mediated chiral resolution of racemic 2-arylpropionate esters due to the high activity and low side effects of the (S)-enantiomers. Esterases are important biocatalysts for chemical synthesis owing to their enantioselectivity, regioselectivity, broad substrate specificity and no need for cofactors. Several bHSL family esterases have been used to resolve racemic 2-arylpropionates. However, each reported enzyme was able to synthesize only one NSAIDs drug, which does not meet the industry requirement for catalysts and limits their application.ResultsThrough careful analysis of the structural information and molecular docking, we present the discovery of key residues that controlled the enantioselectivity of bHSL carboxylesterases to ethyl 2-arylpropionates. Est924 was identified as a bHSL family esterase and a promising catalyst for kinetic resolution of racemic ethyl 2-arylpropionates with sight (R)-stereopreference. Using Est924 as the starting enzyme, protein engineering at these key residues was conducted, and the substitution of A203 was shown to affect the enantioselectivity. The stereopreference of the mutant M1(A203W) was inverted to ethyl 2-(S)-arylpropionates, and this stereopreference was further improved in variant M3(I202F/A203W/G208F). In addition, the optimal variant, M3, was also suitable for the resolution of ibuprofen ethyl ester and ketoprofen ethyl ester, and their efficient (S)-isomers were synthesized.ConclusionsOur results suggested that Est924 variants could kinetically resolve economically important racemates for industrial production and further offer the opportunity for the rational design of enzyme enantioselectivity.

Surfactant effect on enhancing (S)-naproxen prodrug production from racemic naproxen by lipase

Effect of Salts on Activity, Stability and Enantioselectivity of Candida Rugosa Lipase in Isooctane

Extraction of Candida Rugosa Lipase from Aqueous Solutions into Organic Solvents by Forming an Ion‐paired Complex with AOT

Effect of lipase immobilization on resolution of ( R, S )-2-octanol in nonaqueous media using modified ultrastable-Y molecular sieve as support

An Immobilized Lipase with High Enantioselectivity in the Resolution of Racemic Ibuprofen

Effect of Immobilization by Modified Ultrastable-Y Molecular Sieve on the Resolution of (R,s)-2-octanol in Nonaqueous Media by Lipase

Efficient Improving the Activity and Enantioselectivity of Candida Rugosa Lipase for the Resolution of Naproxen by Enzyme Immobilization on MCM-41 Mesoporous Molecular Sieve

Enhanced Production of (S)-2-arylpropionic Acids by Protein Engineering and Whole-Cell Catalysis

Enantioselective Hydrolysis of Naproxen Ethyl Ester Catalyzed by Monoclonal Antibodies

Proposal of the Possible Surfactant Role in the Mass Transfer Process of Naproxen Recovered from Aqueous Solutions Using Emulsion Liquid Membranes

Enantioselective Hydrolysis of Naproxen Ethyl Ester Catalyzed by Polyclonal Antibodies

Protein Engineering for Enhanced Enantioselectivity of Carboxylesterase Est924 Toward Ethyl 2-Arylpropionates

Efficient resolution of naproxen by inclusion crystallization with N-octyl-glucamine and structure characterization of the inclusion complex

Chemo-enzymatic synthesis of optically active polymeric prodrug of naproxen, ketoprofen and ibuprofen

Preparation of molecularly imprinted silica particles with amino functionality for chiral separation of (±)-naproxen

Novel Naproxen Salts with Increased Skin Permeability

Characterization of naproxen salts with amino acid esters and their application in topical skin preparations

The Preparation of Polymerizable, Optically Active Non-Steroidal Anti-Inflammatory Drugs Derivatives by Irreversible Enzymatic Methods

Enantioselective enzymatic hydrolysis of racemic drugs by encapsulation in sol-gel magnetic sporopollenin

Lipase Catalysis in Presence of Nonionic Surfactants

Effect of Surfactant Structure on the Superactivity of Candida rugosa Lipase.